Graphite delivers 4x return on sale of life sciences data platform Beacon
Graphite Capital has agreed the sale of life sciences data and workflow platform Beacon to Corten Capital, in a deal that is expected to deliver of 4x cash return on the firm's original investment in Hanson Wade in 2019.
Original Source
Read the full article at Privateequitywire →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.